Close Menu

NEW YORK — Co-Diagnostics on Tuesday reported third quarter revenues of $21.8 million, compared with $41,434 in the year-ago period. The steep increase was primarily due to sales of its Logix Smart COVID-19 test for SARS-CoV-2.

Separately on Tuesday, the Salt Lake City-based company said that it received CE marks for two additional SARS-CoV-2 tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.